MediWound (MediWound) Total Liabilities : $34.86 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is MediWound Total Liabilities?

MediWound's Total Liabilities for the quarter that ended in Dec. 2023 was $34.86 Mil.

MediWound's quarterly Total Liabilities increased from Jun. 2023 ($29.44 Mil) to Sep. 2023 ($33.97 Mil) and increased from Sep. 2023 ($33.97 Mil) to Dec. 2023 ($34.86 Mil).

MediWound's annual Total Liabilities increased from Dec. 2021 ($24.33 Mil) to Dec. 2022 ($39.10 Mil) but then declined from Dec. 2022 ($39.10 Mil) to Dec. 2023 ($34.86 Mil).

MediWound Total Liabilities Historical Data

The historical data trend for MediWound's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediWound Total Liabilities Chart

MediWound Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

25.42

23.80

24.33

39.10

34.86

MediWound Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															39.10	35.37	29.44	33.97	34.86

MediWound Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MediWound's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.829	+	(6.35	+	17.229
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.456)
	=	34.86

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	66.459	-	31.595
	=	34.86

MediWound's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.829	+	(6.35	+	17.229
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.456)
	=	34.86

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	66.459	-	31.595
	=	34.86

MediWound Total Liabilities Related Terms

Thank you for viewing the detailed overview of MediWound's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MediWound (MediWound) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediWound Ltd (NAS:MDWD) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

M8W:Germany

Address

42 Hayarkon Street, Yavne, ISR, 8122745

Website

https://www.mediwound.com

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. Its first biopharmaceutical product, NexoBrid removes dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns also referred to as severe burns. NexoBrid is currently in clinical development in North America and is in the process of preparing its Biologics License Application. The company derives its revenue from the United States.